ImCheck ex-CEO on ASCO Oncology Trends, $1.2B Exit and French Biotech | Pierre d’Epenoux | E60
de
Flot.bio x Philip Hemme
2026-06-08 21:02:35
Data de lançamento
47:24
Duração
